Home
>
National Drug Code (NDC)
>
Terazosin Hydrochloride Anhydrous
Terazosin Hydrochloride Anhydrous - 51079-938-20 - (Terazosin Hydrochloride Anhydrous)
Drug Information of Terazosin Hydrochloride Anhydrous
| Product NDC: | 51079-938 |
| Proprietary Name: | Terazosin Hydrochloride Anhydrous |
| Non Proprietary Name: | Terazosin Hydrochloride Anhydrous |
| Active Ingredient(s): | 5 mg/1 & nbsp; Terazosin Hydrochloride Anhydrous |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Terazosin Hydrochloride Anhydrous
| Product NDC: | 51079-938 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075140 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110128 |
Package Information of Terazosin Hydrochloride Anhydrous
| Package NDC: | 51079-938-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-938-20) > 1 CAPSULE in 1 BLISTER PACK (51079-938-01) |
NDC Information of Terazosin Hydrochloride Anhydrous
| NDC Code | 51079-938-20 |
| Proprietary Name | Terazosin Hydrochloride Anhydrous |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-938-20) > 1 CAPSULE in 1 BLISTER PACK (51079-938-01) |
| Product NDC | 51079-938 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Terazosin Hydrochloride Anhydrous |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110128 |
| Marketing Category Name | ANDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
